Lifecore Biomedical receives redemption notices for all Series A Preferred Stock; $52.1M due Dec 28, 2026

LIFECORE BIOMEDICAL, INC. DE

Holders of all 49,263 Series A Preferred shares (100% outstanding) submitted redemption notices on June 29-30, 2026.
Redemption price $1,000/share plus accrued dividends; total ~$52.1M due Dec 28, 2026.
Company had $38.1M total liquidity as of March 31, 2026 ($20.8M cash, $17.3M revolver availability).
Company must obtain lender consent to pay redemption; otherwise 1% monthly interest on unpaid balance.
Company evaluating strategic alternatives including debt/equity financing or other transactions to fund redemption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.